Grow Therapy
Grow Therapy raises $88M Series D at $1.2B valuation
Quick Facts
Grow Therapy: Series D Funding Round
Grow Therapy has successfully raised $88M in Series D funding, reaching a valuation of $1.2B.
Company Overview
Mental health therapy platform
Funding Details
The Series D round was led by TCV, with participation from Transformation Capital.
Company Information
- Headquarters: New York, NY
- Founded: 2020
- Employees: 400+
- Category: HealthTech
Investment
Grow Therapy plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- TCV: Verified investor in Series D
- Transformation Capital: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
